Clinical Trial Update: Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART) [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes efforts to identify effective LY01021 doses for controlled ovarian hyperstimulation in women undergoing assisted reproductiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• LY01021

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Assisted Reproduction | Phase 2 | Status: ACTIVE_NOT_RECRUITING